Breaking News Instant updates and real-time market news.

BUD

AB InBev

$70.77

0.56 (0.80%)

06:18
01/11/19
01/11
06:18
01/11/19
06:18

AB InBev has no comment on speculation about Asia business IPO, Reuters says

Anheuser-Busch InBev spokesperson indicated that the company is committed to business in the Asia region but did not comment further on the recent press speculation about its spin-off, Reuters reports. Reference Link

BUD AB InBev
$70.77

0.56 (0.80%)

11/12/18
ARGS
11/12/18
DOWNGRADE
ARGS
Hold
AB InBev downgraded to Hold from Buy at Argus
Argus analyst David Coleman downgraded Anheuser-Busch In Bev to Hold from Buy after the company cut the dividend in half, which he believes reduces the attraction of the stock to income investors. He also said the company has been "erratic" on earnings, noting that AB InBev has missed forecasts in three of the past five quarters.
11/12/18
11/12/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Yelp (YELP) downgraded to Hold om Buy at SunTrust with analyst Matthew Thornton citing a surprising and disappointing set of Q3 results following a "stellar" first half of 2018, highlighted by the return of sales execution issues, yielding an unexpected slowdown in gross account adds and continued churn. 2. Cheesecake Factory (CAKE) downgraded to Underweight from Equal Weight at Barclays with analyst Jeffrey Bernstein saying he sees headwinds persisting following the company's "disappointing" Q3 results and views the valuation as full at current share levels. 3. Infinity Pharmaceuticals (INFI) downgraded to Underweight from Neutral at JPMorgan and to Market Perform at Wells Fargo. 4. Skyworks (SWKS) downgraded to Neutral from Buy at Citi with analyst Atif Malik saying the company is being impacted by broad smartphone weakness, disappointing unit sales of Apple's (AAPL) iPhone XR, and a high Apple concentration, which represented 39% of sales in fiscal 2019. 5. AB InBev (BUD) downgraded to Hold from Buy at Argus with analyst David Coleman citing the company's dividend cut, which he believes reduces the attraction of the stock to income investors. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/11/18
OTRG
12/11/18
NO CHANGE
OTRG
MillerCoors and ABI Q4 trends lag overall US beer category, says OTR Global
OTR Global's US beer Q4 distributor checks indicate MillerCoors (TAP) and ABI (BUD) volumes lagged the overall beer category. The firm said domestic premium light beers continued to struggle, while flavored malt beverages and imports boosted overall beer volumes.
01/04/19
GSCO
01/04/19
DOWNGRADE
GSCO
Neutral
AB InBev downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs downgraded AB InBev to Neutral from Buy, saying that while the company is better positioned than its industry peers, it is "not immune from rising competition".

TODAY'S FREE FLY STORIES

DRNA

Dicerna

$10.76

-0.395 (-3.54%)

07:08
01/22/19
01/22
07:08
01/22/19
07:08
Upgrade
Dicerna rating change  »

Dicerna upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRV

Travelers

$123.97

1.03 (0.84%)

07:07
01/22/19
01/22
07:07
01/22/19
07:07
Hot Stocks
Travelers reports Q4 return on equity 10.9% »

Reports Q4 core return on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

VYGR

Voyager Therapeutics

$8.27

-0.22 (-2.59%)

, RHHBY

Roche

$0.00

(0.00%)

07:07
01/22/19
01/22
07:07
01/22/19
07:07
Hot Stocks
Voyager Therapeutics names Robert Hesslein as general counsel »

Voyager Therapeutics…

VYGR

Voyager Therapeutics

$8.27

-0.22 (-2.59%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 01

    Feb

  • 18

    Mar

CAPR

Capricor Therapeutics

$0.62

-0.007 (-1.11%)

07:07
01/22/19
01/22
07:07
01/22/19
07:07
Hot Stocks
Capricor Therapeutics announces outcome of FDA meeting for CAP-1002 »

Capricor Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AUPH

Aurinia Pharmaceuticals

$7.54

0.11 (1.48%)

07:07
01/22/19
01/22
07:07
01/22/19
07:07
Hot Stocks
Breaking Hot Stocks news story on Aurinia Pharmaceuticals »

Aurinia Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

REXR

Rexford Industrial

$32.00

0.225 (0.71%)

07:07
01/22/19
01/22
07:07
01/22/19
07:07
Hot Stocks
Rexford Industrial acquires two industrial properties for $27.6M »

Rexford Industrial Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$87.31

-0.29 (-0.33%)

07:06
01/22/19
01/22
07:06
01/22/19
07:06
Hot Stocks
Medtronic announces new data shared on IN.PACT Admiral DCB »

Medtronic announced new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jan

  • 18

    May

  • 28

    May

BG

Bunge

$52.95

0.745 (1.43%)

07:06
01/22/19
01/22
07:06
01/22/19
07:06
Hot Stocks
Bunge says Lupo, Bachrach, Boilini won't stand for re-election to board »

As part of Bunge's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AUPH

Aurinia Pharmaceuticals

$7.54

0.11 (1.48%)

07:05
01/22/19
01/22
07:05
01/22/19
07:05
Hot Stocks
Aurinia says VOS demonstrates statistically superior efficacy versus Restasis »

Aurinia Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

07:05
01/22/19
01/22
07:05
01/22/19
07:05
General news
Global stock markets under pressure after gloomy IMF report. »

Global stock markets…

BG

Bunge

$52.95

0.745 (1.43%)

07:04
01/22/19
01/22
07:04
01/22/19
07:04
Hot Stocks
Bunge sees FY18 total segment adjusted EBIT below previously disclosed range »

The company provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPGP

IPG Photonics

$132.54

3.37 (2.61%)

07:04
01/22/19
01/22
07:04
01/22/19
07:04
Hot Stocks
IPG Photonics to acquire Padtec SND »

IPG Photonics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$126.64

1.37 (1.09%)

07:04
01/22/19
01/22
07:04
01/22/19
07:04
Hot Stocks
Centene subsidiary selected by Arizona's Department of Corrections »

Centene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 28

    May

QURE

uniQure

$31.29

-0.02 (-0.06%)

07:04
01/22/19
01/22
07:04
01/22/19
07:04
Hot Stocks
uniQure announces FDA clearance of AMT-130 NDA in Huntington's disease »

uniQure N.V. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNCE

Concert Pharmaceuticals

$14.21

-0.065 (-0.46%)

07:04
01/22/19
01/22
07:04
01/22/19
07:04
Hot Stocks
Concert completes enrollment of 12 mg cohort in CTP-543 Phase 2a trial »

Concert Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 30

    Jan

  • 12

    Feb

  • 13

    Feb

RCKT

Rocket Pharmaceuticals

$16.00

0.23 (1.46%)

07:03
01/22/19
01/22
07:03
01/22/19
07:03
Hot Stocks
Rocket Pharmaceuticals announces FDA clearance of IND application for RP-A501 »

Rocket Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSTI

Pluristem

$1.12

(0.00%)

07:03
01/22/19
01/22
07:03
01/22/19
07:03
Hot Stocks
Pluristem to collaborate with IDF in treatment of burn injuries »

Pluristem Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLRY

Tilray

$77.14

-6.17 (-7.41%)

07:02
01/22/19
01/22
07:02
01/22/19
07:02
Hot Stocks
Tilray to acquire Natura Naturals for up to C$70M »

Tilray announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BG

Bunge

$52.95

0.745 (1.43%)

, CAG

Conagra Brands

$21.58

0.34 (1.60%)

07:02
01/22/19
01/22
07:02
01/22/19
07:02
Hot Stocks
Bunge names Gregory Heckman as acting CEO »

Bunge (BG) announced that…

BG

Bunge

$52.95

0.745 (1.43%)

CAG

Conagra Brands

$21.58

0.34 (1.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

CGEN

Compugen

$3.18

0.07 (2.25%)

07:02
01/22/19
01/22
07:02
01/22/19
07:02
Hot Stocks
Compugen announces publication of preclinical data on PVRIG »

Compugen announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSU

Kansas City Southern

$110.57

6.4 (6.14%)

07:00
01/22/19
01/22
07:00
01/22/19
07:00
Recommendations
Kansas City Southern analyst commentary  »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRV

Travelers

$123.97

1.03 (0.84%)

06:58
01/22/19
01/22
06:58
01/22/19
06:58
Hot Stocks
Travelers reports Q4 consolidated combined ratio of 97.5% »

Fourth quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

TRV

Travelers

$123.97

1.03 (0.84%)

06:58
01/22/19
01/22
06:58
01/22/19
06:58
Hot Stocks
Travelers reports Q4 book value per share $86.84 »

Book value per share of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

CONN

Conn's

$19.65

0.31 (1.60%)

06:57
01/22/19
01/22
06:57
01/22/19
06:57
Recommendations
Conn's analyst commentary  »

Conn's price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRX

Amneal Pharmaceuticals

$12.41

-0.07 (-0.56%)

06:57
01/22/19
01/22
06:57
01/22/19
06:57
Hot Stocks
Amneal Pharmaceuticals appoints Todd Branning as CFO »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.